title: Enhancing Immunogenicity of Cancer Vaccines: QS-21 as an Immune Adjuvant.
abstract: Saponins comprise a class of plant natural products that incorporate a lipophilic terpenoid core, to which is appended one or more carbohydrate residues. They are amphiphilic molecules and often exhibit toxic biological profiles, likely as a result of their roles as vital components in protective coatings to defend against phytopathogen infection and insect predation. The most notable of adjuvant-active saponins investigated for vaccine development come from the Chilean Soapbark Tree,Quillaja saponaria(i.e.,QS). More than 30 years ago, semi-purified extracts (i.e., Quil A) from the cortex ofQuillaja saponariawere found to be highly effective as adjuvants in veterinary vaccines. However, due to significant and variable toxicity effects, Quil A was not deemed appropriate for human vaccines. More refined purification methods have led to multiple fractions which are derived from the original plant extract. As such, QS-21 to date appears to be one of the more scientifically interesting and robust adjuvants in use in vaccinology. The role of QS-21 as an adjuvant for use in a variety of cancer vaccine trials and its comparison to other adjuvants is discussed in this review.
authors.affiliation: Member, Molecular Pharmacology and Chemistry Program, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, NY.
authors.forename: David Y
authors.initials: DY
authors.lastname: Gin
authors.affiliation: Associate Attending Physician, Genitourinary Oncology Service, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, NY, and Associate Professor of Medicine, Weill-Cornell Medical College, NY.
authors.forename: Susan F
authors.initials: SF
authors.lastname: Slovin
keywords: QS-21; adjuvant; prostate cancer; vaccines